title: Pretreatment with topical glucocorticosteroids to enhance the antitumour efficacy of imiquimod: long-term follow-up in Bowen disease.
authors.affiliation: Department of Dermatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Okazaki
authors.affiliation: Department of Dermatology, Saitama Medical University, Saitama Medical Center, Kawagoe, Saitama, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Fukuda
authors.affiliation: Department of Dermatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Yamazaki
authors.affiliation: Department of Dermatology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Shiohara
mesh_terms: D000279:Administration, Cutaneous; D000368:Aged; D000634:Aminoquinolines / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001913:Bowen's Disease / Q000188:drug therapy*; D017252:CD3 Complex / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects; D002990:Clobetasol / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D051858:Forkhead Transcription Factors / Q000378:metabolism; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D000077271:Imiquimod; D009824:Ointments; D012878:Skin Neoplasms / Q000188:drug therapy*; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects; D016896:Treatment Outcome
chemical_list: D000634:Aminoquinolines; D000970:Antineoplastic Agents; D017252:CD3 Complex; C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D005938:Glucocorticoids; D009824:Ointments; D002990:Clobetasol; D000077271:Imiquimod